| | Class 2 Device Recall Kaluza C Software |  |
| Date Initiated by Firm | June 23, 2021 |
| Create Date | August 11, 2021 |
| Recall Status1 |
Terminated 3 on July 02, 2026 |
| Recall Number | Z-2241-2021 |
| Recall Event ID |
88247 |
| Product Classification |
Calculator/data processing module, for clinical use - Product Code JQP
|
| Product | Kaluza C Flow Cytometry Software Versions: 1.0*, 1.1.1 and 1.1.2
Kits:
C10574 - Kaluza C Single Perpetual License
C10575 - Kaluza C Single User 1-year License
C10576 - Kaluza C 10 User Network License
C10577 - Kaluza C 5 User Network License
C10578 - Kaluza C Single Perpetual Educational License
C10579 - Kaluza C Single User 1-year Educational License
C10580 - Kaluza C 10 User Network Educational License
C10581 - Kaluza C 5 User Network Educational License and
C21166 - Kaluza C Program DVD v1.0 |
| Code Information |
Versions: 1.0, 1.1.1 and 1.1.2 |
| FEI Number |
3000203293
|
Recalling Firm/ Manufacturer |
Beckman Coulter, Inc. 11800 Sw 147th Ave Miami FL 33196-2500
|
| For Additional Information Contact | Customer Support Center 800-369-0333 |
Manufacturer Reason for Recall | Software anomalies that may lead to the generation of erroneous results. |
FDA Determined Cause 2 | Under Investigation by firm |
| Action | The firm notified its consignees via mail and email on 06/28/2021. Customers were provided with actions to take via customer letter. New customers will be affected by the issue. A stuffer letter will be implemented in new product to notify new customers. New customers downloading Kaluza software from the website will be notified of the issue via email during the downloading process. Product Disposition: A Stop Ship was placed on Kaluza software in order to
implement the letter in new kits.
|
| Quantity in Commerce | 1,085 (482 US & 603 OUS) |
| Distribution | Worldwide distribution - US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, FL, GA, IL, IN, KS, LA, MA, MD, ME, MI, MN, MS, NC, NE, NJ, NV, NY, OH, OK, OR, PA, TN, TX, UT, VA, WA, WI, WV, and Hawaii. The countries of Australia, Austria, Bahrain, Belgium, Bolivia, Brazil, Canada, China, Czech Republic, Denmark, Ecuador, Egypt, France, Germany, Greece, Guadeloupe, Hong Kong, Hungary, India, Israel, Italy, Kenya, Korea, Kuwait, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, Panama, Peru, Poland, Portugal, Reunion, Saudi Arabia, Slovakia, South Africa, Sweden, Switzerland, Taiwan, Thailand, Tunisia, U.A.E, Ukraine, United Kingdom, and Vietnam. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|